Society for Pharmacoeconomics and Outcomes Research (ISPOR) 7th Asia Pacific Conference

 

Department of Pharmacy made a splash at the recently concluded International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 7th Asia Pacific Conference held in Suntec City , Singapore, from 3 to 6 Sep 2016. This meeting was attended by more than 1,300 participants from 50 countries and 750 abstracts were received. A/P Chui Wai Keung was the event co-chair.

 

A/P Koh Hwee Ling was an invited speaker at a forum titled “Integrating Evidence-Based and Cost-Effective Complementary and Alternative Medicine into the Health Care Systems in Asia” while Dr Wee Hwee Lin was an invited speaker at a forum titled “Big Data in Asia-Pacific – A Valuable Resource for Better Health Care Decisions: Experiences and Lessons Learned in Australia, Japan, Singapore, South Korea, and Taiwan”. In addition, Dr Wee conducted a pre-conference Short Course, participated to speak at an issue panel, and organized two workshops. Our PhD students under the supervision of A/P Alexandre Chan, Dr Ong Pei Shi and Dr Wee Hwee Lin were also actively involved in the conference, giving a total of 5 oral presentations and 7 poster presentations.

 

 

ispor2016_cwk2It was awards galore for our department. A/P Chui Wai Keung received the ISPOR Distinguished Service Award for his contributions to the successful organization of the conference. Our students and alumni swept 4 out of 6 podium research presentation awards.

 

The three winners were current PhD, former PhD and former Final Year Project students in Dr Wee Hwee Lin’s research group. While one of the winners is current PhD student under A/P Alexandre Chan’s research group. Details of the winners below:

 

Dr Zhao Yingjiao

CE1-CLINICAL OUTCOMES AND COST-EFFECTIVENESS OF NOVEL ORAL ANTICOAGULANTS INCORPORATING REAL-WORLD ELDERLY PATIENTS WITH ATRIAL FIBRILLATION

Zhao YJ1, Lin L1, Zhou HJ1, Khoo AL1, Tan KT2, Chew AP3, Foo CG4, Oh CT5, Lim WS3, Lim BP1

1Pharmacy and Therapeutics Office, Group Corporate Development, National Healthcare Group, Singapore, Singapore,2Department of Pharmacy, Tan Tock Seng Hospital, Singapore, Singapore, 3Department of Geriatric Medicine, Tan Tock Seng Hospital, Singapore, Singapore, 4Department of Cardiology, Tan Tock Seng Hospital, Singapore, Singapore, 5Department of Neurology, National Neuroscience Institute, Singapore, Singapore, Singapore

 

Mr Kwan Yu Heng

RM4-RELIABILITY AND VALIDITY OF THE HEALTH ASSESSMENT QUESTIONNAIRE (HAQ) IN PATIENTS WITH SPONDYLOARTHRITIS

Kwan YH1, Yong ST2, Fong W2, Lui NL2, Malhotra R1, Thumboo J3, Ostbye T1

1Duke-NUS Medical School, Singapore, Singapore, 2Singapore General Hospital, Singapore, Singapore, 3Singhealth, Singapore, Singapore

 

Ms Wang Wei Vivian

RM3-COMPARISON OF CAREGIVER-RATED 3-LEVEL EUROQOL-5D (EQ-5D-3L) AND HEALTH UTILITIES INDEX MARK 3 (HUI3) IN PATIENTS WITH DEMENTIA IN SINGAPORE

Wang VW1, Kandiah N2, Lin X2, Wee HL1
1National University of Singapore, Singapore, Singapore, 2National Neuroscience Institute, Singapore, Singapore

 

Mr Sreemanee Dorajoo

HC4-DERIVATION AND EXTERNAL VALIDATION OF AN EARLY READMISSION RISK PREDICTION MODEL

Dorajoo SR1, See V1, Chan CT1, Tan ZY2, Koomanan N3, Ong TT4, Razak SM4, Yap CW1, Chan A1

1National University of Singapore, Singapore, Singapore, 2Khoo Teck Puat Hospital, Singapore, Singapore, 3Singapore General Hospital, Singapore, Singapore, 4Temasek Polytechnic, Singapore, Singapore